A 2142 New York Assembly · 2025 Regular Session

Enacts the medical psilocybin act

This bill creates a regulated program to allow the medical use of psilocybin, a compound found in certain mushrooms, for treating specific health conditions. It directly affects qualified patients diagnosed with issues like treatment-resistant depression, PTSD, or substance use disorders, as well as licensed healthcare providers and designated caregivers. Under the act, the state would establish rules for licensing producers, setting safety standards, and requiring that patients receive psilocybin in a controlled, supervised setting. The legislation also provides legal protection from criminal penalties for the possession and use of psilocybin when obtained through this new medical framework.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2025

Committee Review

Floor Vote

Governor

Introduced Jan 15, 2025 Last action May 8, 2026

Maddy AI version diff · 1 comparison

What changed between versions

A2142 → A2142A · 6 edits

MODERATE

The bill was amended to shift from a regulated adult-use model to a strict medical-only framework. The scope was narrowed to authorize psilocybin solely for treating specific medical conditions like depression and PTSD, removing all provisions for recreational use and commercial cultivation. Eligibility is now limited to patients diagnosed with qualifying conditions by licensed healthcare providers, and the bill was expanded to include amendments to the Penal Law to support this medical authorization.

Scope change

The bill's scope changed from a comprehensive public health framework allowing both adult recreational use and medical use to a strictly medical program. It now authorizes psilocybin only for treating qualified medical conditions and removes all references to adult use, commercial cultivation, and support services for non-medical purposes.

SCOPE

Removed all provisions establishing a framework for regulated adult use of psilocybin and commercial cultivation licenses.

Deleted the section on taxation of psilocybin regulated activities, as the bill no longer supports a commercial market.

ELIGIBILITY

Changed the definition of eligible users from 'adults' to 'qualified patients' who must be diagnosed with specific conditions like major depression or PTSD by a licensed healthcare provider.

DEFINITION

Replaced broad definitions of 'cultivator' and 'business enterprise' with new definitions for 'licensed producer' and 'licensed healthcare provider' focused on medical treatment.

ENFORCEMENT

Added amendments to the Penal Law to authorize medical use, which was not present in the original version focused on public health administration.

REQUIREMENT

Replaced general health screening forms with a requirement for a formal health qualification evaluation by a licensed healthcare provider.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

May 8, 2026

Lower · Passed

PRINT NUMBER 2142A

lower

May 8, 2026

Lower · Passed

AMEND (T) AND RECOMMIT TO HEALTH

lower

Jan 7, 2026

Committee

REFERRED TO HEALTH

lower

Jan 15, 2025

Committee

REFERRED TO HEALTH

lower

1 primary · 9 co-sponsors